
Sanofi has said it will stop investment and research into creating new diabetes and cardiovascular drugs, as part of the …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

